Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKALL14: Rituximab and Nelarabine in Adult ALL
NCT01085617Phase 3Completed
- Sponsor
- University College London
- Start
- Dec 2010
- Primary completion
- Feb 2025
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 3 trial of rituximab, nelarabine in acute lymphoblastic leukemia (ALL), sponsored by University College London. Started Dec 2010; status: completed.
02
Drugs
rituximabnelarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01085617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01085617.